Literature DB >> 23419223

Depression as a risk factor for diabetes: a meta-analysis of longitudinal studies.

Francesco Rotella1, Edoardo Mannucci.   

Abstract

OBJECTIVE: The present meta-analysis aimed to assess the risk of incident diabetes associated with clinical depression, depressive symptoms, or both in nondiabetic subjects. DATA SOURCES: We performed a MEDLINE search for studies published in the English language using the search string diabetes AND (depression OR antidepressant). The search included studies from any date to December 30, 2011. STUDY SELECTION: 1,898 studies were independently assessed for eligibility, and longitudinal studies that assessed the risk of incident diabetes in subjects with or without clinical depression were selected. DATA EXTRACTION: Study design and characteristics were verified for each study. A meta-analysis was performed for unadjusted and adjusted risk ratios of incident diabetes in subjects with depression by using a random-effects model. Additional analyses were performed to assess heterogeneity, publication bias, and specific hazard ratios for diabetes associated with antidepressant drug use.
RESULTS: The 23 studies included in the meta-analysis enrolled 424,557 subjects, with a mean follow-up of 8.3 years and 19,977 cases of incident diabetes. A higher incidence of diabetes was found in depressed versus nondepressed subjects (0.72% vs 0.47% yearly), with unadjusted and adjusted risk (95% CI) of 1.56 (1.37-1.77) and 1.38 (1.23-1.55), respectively (both P values < .001). The use of antidepressant drugs and untreated depression were associated with an adjusted risk of diabetes of 1.68 (1.17-2.40) (P = .005) and 1.56 (0.92-2.65) (P = .09).
CONCLUSIONS: Depressive symptoms are associated with a significantly increased risk for incident diabetes. This association cannot be entirely explained by the use of antidepressant drugs or being overweight. Pathogenetic mechanisms connecting depression with diabetes deserve further exploration. Depression should be included among risk factors that indicate intensified screening for diabetes. © Copyright 2013 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23419223     DOI: 10.4088/JCP.12r07922

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  107 in total

1.  Is the Chinese medicinal formula Guipi Decoction () effective as an adjunctive treatment for depression? A meta-analysis of randomized controlled trials.

Authors:  Chen-Xia Sheng; Ze-Qi Chen; Han-Jin Cui; A-Li Yang; Cong Wang; Zhe Wang; Nan-Xiang Su; Tao Tang
Journal:  Chin J Integr Med       Date:  2015-10-10       Impact factor: 1.978

2.  Pilot randomized controlled trial of a mindfulness-based group intervention in adolescent girls at risk for type 2 diabetes with depressive symptoms.

Authors:  Lauren B Shomaker; Stephanie Bruggink; Bernadette Pivarunas; Amanda Skoranski; Jillian Foss; Ella Chaffin; Stephanie Dalager; Shelly Annameier; Jordan Quaglia; Kirk Warren Brown; Patricia Broderick; Christopher Bell
Journal:  Complement Ther Med       Date:  2017-04-15       Impact factor: 2.446

3.  Role of Serotonin Transporter in Antidepressant-Induced Diabetes Mellitus: A Pharmacoepidemiological-Pharmacodynamic Study in VigiBase®.

Authors:  Thi Thu Ha Nguyen; Anne Roussin; Vanessa Rousseau; Jean-Louis Montastruc; François Montastruc
Journal:  Drug Saf       Date:  2018-11       Impact factor: 5.606

4.  Postmenopausal Symptoms in Female Veterans with Type 2 Diabetes: Glucose Control and Symptom Severity.

Authors:  Patricia A Rouen; Sarah L Krein; Nancy E Reame
Journal:  J Womens Health (Larchmt)       Date:  2015-05-04       Impact factor: 2.681

Review 5.  Metabolic/inflammatory/vascular comorbidity in psychiatric disorders; soluble epoxide hydrolase (sEH) as a possible new target.

Authors:  W Swardfager; M Hennebelle; D Yu; B D Hammock; A J Levitt; K Hashimoto; A Y Taha
Journal:  Neurosci Biobehav Rev       Date:  2018-02-02       Impact factor: 8.989

6.  Depression and risk of type 2 diabetes: the potential role of metabolic factors.

Authors:  N Schmitz; S S Deschênes; R J Burns; K J Smith; A Lesage; I Strychar; R Rabasa-Lhoret; C Freitas; E Graham; P Awadalla; J L Wang
Journal:  Mol Psychiatry       Date:  2016-02-23       Impact factor: 15.992

7.  Measurement invariance of the patient health questionnaire-9 (PHQ-9) depression screener in U.S. adults across sex, race/ethnicity, and education level: NHANES 2005-2016.

Authors:  Jay S Patel; Youngha Oh; Kevin L Rand; Wei Wu; Melissa A Cyders; Kurt Kroenke; Jesse C Stewart
Journal:  Depress Anxiety       Date:  2019-07-29       Impact factor: 6.505

8.  Adverse Childhood Experiences and the Risk of Diabetes: Examining the Roles of Depressive Symptoms and Cardiometabolic Dysregulations in the Whitehall II Cohort Study.

Authors:  Sonya S Deschênes; Eva Graham; Mika Kivimäki; Norbert Schmitz
Journal:  Diabetes Care       Date:  2018-08-02       Impact factor: 19.112

9.  Psychological conditions in adults with diabetes.

Authors:  Mary de Groot; Sherita Hill Golden; Julie Wagner
Journal:  Am Psychol       Date:  2016-10

10.  State of the science: depression and type 2 diabetes.

Authors:  Sue Penckofer; Todd Doyle; Mary Byrn; Patrick J Lustman
Journal:  West J Nurs Res       Date:  2014-02-27       Impact factor: 1.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.